Your browser version may not work well with NCBI's Web applications. More information here...
1: Expert Rev Anticancer Ther. 2002 Oct;2(5):481.Click here to read Links

KS Biomedix licenses TransMID brain cancer product to Nycomed in European collaboration.

[No authors listed]

PMID: 12382509 [PubMed - indexed for MEDLINE]